94716 ⎘
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms; Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings [b, e]-condensed
C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME
#2C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME
#3Synthesis of Vinylic Protected Alcohol Intermediates
#4Piperazine substituted azapine derivatives and uses thereof
#5C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
#6Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents
#7Compounds that inhibit human DNA ligases and methods of treating cancer
#8Amino acid conjugates of quetiapine, process for making and using the same
#9Compounds that inhibit human DNA ligases and methods of treating cancer
#10Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#11Amino acid conjugates of quetiapine, process for making and using the same
#12INHIBITORS OF HISTONE DEACETYLASE
#13Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same
#14Compounds that inhibit human DNA ligases and methods of treating cancer
#15Novel organic electroluminescent compounds and organic electroluminescent device using the same
#16Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#17N-Acylated lipophilic amino acid derivatives
#18Amide derivatives
#19Pesticidal dibenzo(hetero)azepine derivatives
#20N-acylated lipophilic amino acid derivatives